Turkish Journal of Medical Sciences
Volume 51

Number 5

Article 61

1-1-2021

The protective effect of boric acid on cholestatic rat liver
ischemia reperfusion injury
SERKAN GÜLER
ARİF ASLANER
HAMİT YAŞAR ELLİDAĞ
ŞENAY YILDIRIM
TUĞRUL ÇAKIR

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
GÜLER, SERKAN; ASLANER, ARİF; ELLİDAĞ, HAMİT YAŞAR; YILDIRIM, ŞENAY; and ÇAKIR, TUĞRUL
(2021) "The protective effect of boric acid on cholestatic rat liver ischemia reperfusion injury," Turkish
Journal of Medical Sciences: Vol. 51: No. 5, Article 61. https://doi.org/10.3906/sag-2101-153
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss5/61

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences

Turk J Med Sci
(2021) 51: 2716-2726
© TÜBİTAK
doi:10.3906/sag-2101-153

http://journals.tubitak.gov.tr/medical/

Research Article

The protective effect of boric acid on cholestatic rat liver ischemia reperfusion injury
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Background/aim: To evaluate the potential protective effects of boric acid (BA) in experimental cholestatic liver ischemia reperfusion
(IR) injury model.
Materials and methods: The study included 24 female rats which were divided into 3 groups each containing 8 rats. The control group
(Group 1) only received laparotomy. In the IR group (Group 2) biliary tract ligation was applied and 1 week later 45 min ischemia and
1 h reperfusion with relaparotomy without any treatment was implemented. In the treatment BA+IR group (Group 3). 1 week after the
biliary ligation intraperitoneal administration of 200 mg/kg BA was given 10 min before the ischemia for 45 min and reperfusion for 1
h with relaparotomy. Liver tissue and blood samples were taken for histopathological and biochemical examination. Ischemia modified
albumin (IMA), SCUBE1, total antioxidant status (TAS), and total oxidant status (TOS) levels were also examined.
Results: Compared to control, groups IR and BA+IR had higher serum alanine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), total, and direct bilirubin levels. Albumin value was high in the
control group and low in the other groups. In terms of IMA levels there was no significant difference between groups (p > 0.05). When
SCUBE-1 levels were examined groups IR and BA+IR were significantly higher than the group 1. TAS was highest in the group BA+IR
whereas TOS was highest in the group IR and lower in the group BA+IR. In histopathological analysis, loss of intercellular border loss
in hepatocytes, diffuse nuclear pycnosis and mild to moderate neutrophilic cell infiltration were observed in the IR group. Statistically
significant dissociation, hemorrhage and severe neutrophilic cell infiltration were seen in hepatocytes of rats with IR (p < 0.05).
Conclusion: BA has promising results in the treatment of experimental IR injury of the cholestatic liver because of its antioxidant
effects. It may be used in clinical practice after more extensive studies about the effects of BA on IR injury of the cholestatic liver.
Key words: Boric acid, liver, cholestasis, ischemia reperfusion

1. Introduction
Ischemia is defined as the interruption or reduction of
blood flow to the tissue for any reason. Reperfusion is
defined as the normalization of blood flow in ischemic
tissue. IR injury is the damage caused by free oxygen
radicals (FOR) caused by reperfusion and reperfusion in
order to maintain the viability of the tissue [1].
Trauma, shock, liver surgery and transplantation are
among the most common causes of liver IR injury in the
clinic [2]. Many mechanisms have been described regarding
the mechanism of IR injury. As a result of the change in
mitochondrial oxidative phosphorylation decrease in
ATP increase in intracellular calcium and activation of
proteases and phosphatases leading to the deterioration of
cytoskeleton and membrane phospholipids excessive FOR
is formed and causes oxidative stress [3,4].

In the presence of cholestasis, the liver is more
susceptible to reperfusion damage [5,6]. When bile flow is
interrupted sinusoidal endothelial cell damage accelerates;
neutrophil accumulation and kuppfer cell activation are
stimulated [6]. Activated neutrophils and kuppfer cells
are the most important sources of reactive oxygen radicals
in oxidative stress [7,8]. Cholestasis is a common finding
in liver and pancreatic diseases requiring major hepatic
surgery; therefore, cholestatic IR models are more valuable
to reflect this situation.
IMA is an albumin that changes its structure as a
result of ischemia reperfusion injury. In addition to
ischemia, IMA may increase in acute coronary syndrome,
cerebrovascular diseases, liver failure, end-stage renal
disease, severe traumas, pulmonary embolism, sepsis,
diabetes, systemic sclerosis, some neoplastic diseases, and
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infections. In this way, we believe IMA is more clinically
valuable.
Boron or boric acid (BA) is an element found in nature
and is abundant in Turkey. Studies on its clinical use are
quite common. BA has an inhibitory effect on peptidases,
xanthine oxidase, nitric acid synthase, cytochrome b
reductase. In addition, it also affects calcium, phosphorus,
magnesium ion levels and vitamin D, insulin, testosterone,
estrogen, and glucose metabolism [9,10]. It has been shown
in many studies to have antioxidant and antiinflammatory
effects [11–14].
The aim of this experimental study was to investigate the
effects of BA on experimental IR injury of the cholestatic
liver through the evaluation of oxidative stress and
histopathological changes. To the best of our knowledge
this is the first study in the literature to have examined the
effect of BA on cholestatic liver damage caused by IR.
2. Materials and methods
The approval for this study was granted by the Animal
Research Ethics Committee of Antalya Akdeniz University
dated 15.01.2019 and numbered B.30.2.AKD.0.05.07.00/7.
All procedures were applied at Akdeniz University
Experimental Medicine and Animal Laboratory in
accordance with the principles of the National Guidelines
for Experimental Use of Laboratory Animals between
January and March 2019.
2.1. Animals
In this study 24 female Wistar Albino rats weighing
between 200–250 g were used. During both preoperative
and postoperative periods, the rats were housed at cages
with constant environmental conditions (temperature: 23
°C and humidity: 55.5%) and fed with standard laboratory
feed and tap water. Access to food was stopped 12 h before
anesthesia and to water 2 h prior to anesthesia.
2.2. Surgery and experimental protocol
This research aimed to investigate the effects of BA on IR
injury of the cholestatic liver. The rats were randomized
into 3 groups;
Group 1 (Control): Only laparotomy was performed.
After waiting for 1 h and 45 min blood and tissue samples
were taken and the animals were sacrificed. No other
treatment was given.
Group 2 (IR): After laparotomy the common bile duct
was dissected from adjacent tissue and ligated with 3/0
silk sutures. After the procedures each abdominal incision
was closed with 3/0 prolene sutures. Subsequently the
rats were allowed to feed. On the postoperative 7th day
relaparotomy was performed. The portal vein and hepatic
artery were clamped and ischemia was performed for 45
min. Reperfusion was performed for 1 h by opening the
clamp. No other intervention or medication was given.
Liver tissue samples and blood samples from the aorta

were taken for histopathological and biochemical analyses
and the rats were sacrificed.
Group 3 (BA+IR): After laparotomy the common
bile duct was found and dissected from adjacent tissues
and ligated with 3/0 silk sutures. After the procedures
each abdominal incision was closed with 3/0 prolene
sutures. Subsequently the rats were allowed to feed.
On the postoperative 7th day 200 mg/kg BA was given
intraperitoneally. After waiting for 10 min relaparatomy
was performed. The portal vein and hepatic artery
were clamped and ischemia was performed for 45 min.
Reperfusion was performed for 1 h by opening the clamp.
Liver tissue samples and blood samples from the aorta
were taken for histopathological and biochemical analyses
and the rats were sacrificed.
2.3. Biochemical analysis
Routine parameters:
Rat serum albumin (Beckman Coulter Diagnostics,
Brea, CA, USA; catalogue no. OSR6602), alanine
aminotransferase (ALT) (Beckman Coulter Diagnostics,
Brea, CA, USA; catalogue no. OSR6607), aspartate
aminotransferase (AST) (Beckman Coulter Diagnostics,
Brea, CA, USA; catalogue no.OSR6509), alkaline
phosphatase (ALP) (Beckman Coulter Diagnostics, Brea,
CA, USA; catalogue no.OSR6504), total bilirubin (TBIL)
(Beckman Coulter Diagnostics, Brea, CA, USA; catalogue
no.OSR6512), and direct bilirubin (DBIL) (Beckman
Coulter Diagnostics, Brea, CA, USA; catalogue no.
OSR6511) levels were determined using an autoanalyzer
(Beckman AU5800; Beckman Coulter Diagnostics, Brea,
CA, USA).
2.4. Measurement of SCUBE1
Rat serum SCUBE1 levels were quantified using a
commercially available ELISA kit (Bioassay Technology
Laboratory, Shanghai, China; catalogue no. E0948Ra)
according to the manufacturer’ instructions. The
sensitivity of the assay was 0.35 ng/mL with inter- and
intra-assay coefficients of variation of <10%. Assay results
were expressed as ng/mL.
2.5. Measurement of ischemia modified albumin (IMA)
Reduced cobalt–albumin-binding capacity (IMA level)
was measured using the rapid and colorimetric method
developed by Bar-Or et al. [15]. Briefly 200 μL rat serum
was transferred into glass tubes and 50 μL 0.1% CoCl2 *
6H2O (lot S38901-248. Sigma Aldrich, St Louis. MO. USA)
was added. After gentle shaking the mixture incubated for
10 min to ensure sufficient cobalt–albumin binding. Then
50 μL 1.5 mg/mL dithiothreitol (DTT) (lot D5545-1G.
Sigma-Aldrich) was added as a coloring agent. After 2 min
1 mL0.9% NaCl was added to halt the binding between
cobalt and albumin. A blank was prepared for every
specimen: at the DTT addition step. Fifty microliters of
distilled water was used instead of 50 μL 1.5 mg/ml DTT
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to obtain a blank without DTT. The absorbances were
recorded at 470 nm with a spectrophotometer (UV1201.
Shimadzu, Kyoto, Japan). Color formation in specimens
with DTT was compared with color formation in the blank
tubes and the results are expressed as absorbance units.
2.6. Measurement of serum total oxidant status (TOS)
Serum TOS levels were analyzed using an automated
colorimetric measurement method developed by Erel [16].
In this method oxidants in the sample oxidize the ferrous
ion-chelated complex to ferric ion, which makes a colored
complex with a chromogenic in an acidic medium. The
color intensity which can be measured spectrophotometry
is related to the total amount of oxidant molecules present
in the sample. The results are expressed in terms of micro
molar hydrogen peroxide equivalent per liter (μmol H2O2
equiv./l).
2.7. Measurement of serum total antioxidant status (TAS)
Serum TAS levels were analyzed using an automated
colorimetric measurement method developed by Erel [17].
In this method antioxidants in the sample reduce dark
blue-green colored 2,2′-azino-bis (3-ethylbenzthiazoline6-sulfonic acid) (ABTS) radicals to a colorless reduced
ABTS form. The change of absorbance at 660 nm is related
to the total antioxidant level in the sample. This method
determines the antioxidative effect of the sample against
the potent free radical reactions initiated by the produced
hydroxyl radical. The results are expressed as micro molar
Trolox equivalent per liter (μmol Trolox equiv./l).
2.8. Oxidative stress index (OSI)
The percentage ratio of the TOS level to the TAS level is
given as the OSI [18]. For calculation the resulting micro
molar unit of TAS was changed to mmol/L and the OSI
value was calculated according to the following formula:
OSI (arbitrary unit) = TOS (μmol H2O2 equiv./l)/TAS
(μmol Trolox equiv./l).
2.9. Histopathological evaluation
Liver samples were fixed in 10% neutral formalin solution.
After 48 h of fixation tissues were dehydrated through a
series of graded alcohol embedded in paraffin and cut into
4 μm sections using a microtome (Leica RM 2125. Leica
Microsystems Nussloch GmbH. Germany) and stained
with hematoxylin and eosin (H&E). These preparations
were blindly evaluated by the pathologist under a light
microscope.
Hepatic injury was evaluated for severity of hepatic
injury using an ordinal scale as follows: Grade 0 = Minimal
or no evidence of injury; Grade 1 = Mild injury with
cytoplasmic vacuolation and focal nuclear pycnosis; Grade
2 = Moderate to severe injury with nuclear pycnosis,
cytoplasmic hypereosinophilia and loss of intercellular
borders; Grade 3 = Severe necrosis with disintegration
of hepatic cords, hemorrhage and neutrophil infiltration
[19].
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2.10. Statistical analysis
The data obtained after the study were evaluated
statistically using the SPSS package program (IBM Corp.,
SPSS Statistics for Windows, v. 22.0. Armonk, NY, USA).
Mean, median, standard deviation, and frequency values
were used in the descriptive statistics of the data. Three
groups were analyzed using the nonparametric Kruskal–
Wallis test. Mann–Whitney-U test was used for paired
comparisons in subgroup analysis. A p value of < 0.05 was
considered significant.
3. Results
Serum ALT, AST, ALP, LDH, total, and direct bilirubin
levels were low in the control group while it was higher
in the IR and BA+IR group (p < 0.01). There was no
statistically significant difference between these two
groups. In terms of albumin values, albumin values of the
control group were higher, but there was no difference
between the IR group and the BA+IR group (Table).
For SCUBE-1 levels the control group was significantly
lower than the other groups (p < 0.05). The values of
 the
group given BA were lower between the IR group and
the BA+IR group, this difference was not statistically
significant. (p = 0.28) (Figure 1). When IMA levels between
the 3 groups were compared no significant difference was
found between the groups (p > 0.05).
When we look at the total antioxidant capacity (TAS)
the antioxidant capacity of the group given BA was
significantly higher (p = 0.02). When the total oxidant
capacity (TOS) is examined all three groups were
significantly different from each other (p = 0.0019). While
the control group had the lowest TOS values the IR group
had the highest TOS values. While TOS values of the
group given BA were significantly higher than the control
group it was significantly lower than that of the IR group.
Hepatic damage degree of IR group was higher than
other groups (p < 0.001). There was no statistically
significant difference between control group and BA+IR
group for grade parameter (p = 0.36). There was no
or minimal hepatic damage in the livers of rats in the
control group (Figures 2 A and B). In the IR group
loss of intercellular border loss in hepatocytes, diffuse
nuclear pycnosis, and mild to moderate neutrophilic cell
infiltration (grade 2) were observed (Figures 3A and B).
Dissociation, hemorrhage, and severe neutrophilic cell
infiltration in hepatocytes in rats with IR (grade 3) were
seen (Figure 4 A and B). Liver damage was minimal in rats
given BA before IR (Figure 5A and B).
4. Discussion
Liver IR injury is common in complicated surgical
procedures, major trauma, and transplantation cases.
Although ways are sought to reduce this damage the
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Table. Laboratory findings of study groups [the results were presented as median and 95% CI (confidence interval)].
a

b

c

GROUP I

GROUP II

GROUP III

P

P1

P2

P3

SCUBE1*
(ng/mL)

12.27
(10.5–14.88)

19.42
(15.96 - 23.64)

17.17
(13.63–22.10)

<0.01

<0.01

0.01

0.367

TOS**
(μmol H2O2 equiv./L)

6.51
(4.63–17.49)

29.48
(20.77–43.95)

19.98
(13.11–29.85)

<0.01

<0.01

0.02

0.104

TAS***
(μmol Trolox equiv./L)

2.47
(2.37–2.71)

2.28
(2.12–2.67)

3.29
(2.61–3.49)

<0.01

0.16

0.01

<0.01

OSI
(TOS/TAS)#

3.69
(1.89–6.51)

12.99
(9.36–19.1)

6.43
(3.76–9.62)

<0.01

0.01

0.02

<0.01

IMA
(absorbance unit)

0.875
(0.824–0.900)

0.913
(0.867–0.924)

0.920
(0.874–0.952)

0.07

0.234

0.065

0.104

Albumin##
(g/dL)

3.7
(3.5–3.9)

2.75
(2.68– 3.1)

2.85
(2.52–3.1)

<0.01

<0.01

<0.01

0.995

IMAR
(IMA/Albumin)###

0.234
(0.223–0.24)

0.325
(0.291–0.34)

0.323
(0.291–0.37)

<0.01

<0.01

<0.01

0.699

ALP+
(U/L)

108
(46.9–201.7)

271
(210.5–393.7)

250
(219.6–289.6)

<0.01

<0.01

<0.01

0.645

ALT+
(U/L)

52
(45–56.1)

141
(96.3–191)

122
(97.7–226.3)

<0.01

<0.01

<0.01

0.959

AST+
(U/L)

96
(72–133)

568
(398–763)

545
(405–763)

<0.01

<0.01

<0.01

0.999

TBIL+
(mg/dL)

0.275
(0.24–0.34)

10.08
(2.464–12.19)

9.73
(2.28–11.09)

<0.01

<0.01

<0.01

0.505

DBIL+
(mg/dL)

0.01
(0.008–0.02)

6.4
(1.1–7.4)

5.8
(0.991–7.1)

<0.01

<0.01

<0.01

0.507

NOTE = the values are presented as median (min-max). Values are given as median (95%CI). p – between three groups; p1 – between
group-I and group-II; p2 – between group-I and group-III; p3 – between group-II and group III.

development of IR injury cannot be prevented. It is
emphasized that antioxidant substances should be given
before ischemia develops. Experimental studies are still
ongoing because an effective method has not been found
yet.
The most important finding in our study is that
BA exerts a hepatoprotective effect on rats that we have
experimentally developed IR injury of cholestatic liver.
Both histopathological and biochemical results of this
study showed better results in the BA given group
compared to the control group in terms of liver function
and tissue samples.
The liver has a serious blood flow to maintain many
synthesis and secretion functions. Therefore, ischemia is
very sensitive to reperfusion. Damage during reperfusion
is divided into early and late periods. While cellular
damage is seen 2–6 h after reperfusion in the early period
neutrophil dominance is observed in the late period. While

free oxygen radical-mediated damage is prominent in the
early period neutrophil-mediated inflammatory response
is dominant in the late period [20]. Another effective
mechanism in IR injury is the impairment of intracellular
Ca2+, Na+, H+ balances by decreasing mitochondrial ATP
production. The intracellular increase of Ca2+ increase
FOR production and triggers apoptotic mechanisms.
Cholestasis is a clinical condition that occurs as a result of
arrest or slowing of bile flow due to obstruction in intra or
extrahepatic bile ducts. While cholestasis alone increases
Kupffer cell activation and may cause FOR release. IR
injury that develops in the presence of cholestasis is much
more severe [21]. Many surgeons expect the pre-operative
bilirubin levels to decrease in patients with very high
bilirubin levels in elective operations.
There are many studies in the literature regarding liver
IR injury and its prevention. The model of liver IR injury
in cholestatic rats is a newer experimental model. So there
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OSI
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Figure 1. SCUBE-1, TOS, TAS, OSI, IMA, and IMAR levels between groups. SCUBE-1 levels of group I was significantly
lower than the other groups (p < 0.05). TAS of the group III was found significantly higher (p = 0.02). TOS is significantly
different from each other (p = 0.0019). IMA levels between 3 groups were compared no significant difference (p > 0.05).

are fewer studies. This study was planned because BA has
antioxidant effects and boron is a mineral found in our
country.
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Trace element boron which is the characteristic
element of BA may have significant effects on various
metabolic and physiological systems in organism [22].
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Figure 2. A,B. Normal histopathological appearance of the
liver in the control group (H&E, X40) There was no or minimal
hepatic damage in the livers of rats in the control group.

The effects of BA on vitamin, enzyme, hormone, energy
and mineral metabolism have been shown in some studies
[11,23]. The researchers explain the biological effects of
BA by two different hypotheses. In the first hypothesis it is
argued that BA is negative regulator affecting the path of
competitive inhibition in key enzyme reactions [24]. In the
second hypothesis it is argued that BA plays an important
role in cell membrane function, structure and stability
[25].
In a study aimed to use BA as an antioxidant to protect
liver from IR injury they found this beneficial effect
probably originated from radical scavenging activity of
BA [26]. In addition, BA pretreatment prevented ischemia
induced alterations in liver tissue biomolecules. Supporting
this, the protective effect of BA against liver damage
induced by carbon tetrachloride (CCl4) was found in mice
[27]. Besides, BA decreased inflammation, oxidative stress,
and apoptosis caused by cisplatin toxicity and increased
ER stress in kidney [28]. Sogut et al. indicated antioxidant
and antiapoptotic effects of boric acid on hepatoxicity in

Figure 3. A, B: Intercellular border loss in hepatocytes, diffuse
nuclear pycnosis, mild-moderate neutrophilic cell infiltration
(grade 2) (H&E, X100). In the IR group loss of intercellular
border loss in hepatocytes, diffuse nuclear pycnosis and mild to
moderate neutrophilic cell infiltration were observed.

chronic alcohol fed rats [29]. In our study we found BA was
seen to significantly reduce inflammation and fibrosis by
examination of the liver tissue samples histopathologically.
Besides, according to our findings BA increased the
antioxidant capacity and decreased the oxidant capacity
when TAS/TOS levels were examined. On the other hand,
further studies need to focus on highlight the underlying
these effects/mechanisms of BA protection.
IMA is an albumin that changes its structure as a
result of ischemia. In addition to ischemia IMA may
increase in acute coronary syndrome, cerebrovascular
diseases, liver failure, end-stage renal disease, severe
traumas, pulmonary embolism, sepsis, diabetes, systemic
sclerosis, some neoplastic diseases, and infections [30–32].
In a study conducted with IMA in chronic liver disease.
Forty-three individuals with chronic liver disease and
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Figure 4. A, B: Structural disarrangement of liver parenchyma,
hemorrhage, necrotic cells, and severe neutrophilic cell
infiltration in liver of rats with ischemia reperfusion (grade 3)
(H&E, x200). Dissociation, hemorrhage, and severe neutrophilic
cell infiltration in hepatocytes in rats with IR were seen.

28 healthy individuals were compared. IMA values were
found to be significantly higher but AST and ALT albumin
values did not correlate with these high IMA values. IMA
was inversely proportional to albumin [33]. In a study
conducted on 33 healthy children and 33 children with
chronic liver disease, a correlation was found between
fibrous scoring and IMA and no relationship was found
with other biochemical parameters [34]. In a study in
which an experimental acute mesenteric ischemia model
was applied, although an increase was observed in IMA
values at 0, 1, 3, and 6 h no significant difference was found
[35]. In our study albumin values of the control group
were high while the albumin values of the IR group and
the group given BA were low. There was no statistically
significant difference between these two groups. Although
there was a difference in albumin values for 3 groups when
IMA levels were compared no statistically significant
difference was found between 3 groups.
Although there are many methods for evaluating
parenchymal damage in liver IR injury the most frequently
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Figure 5. A, B: Minimal damage to the liver parenchyma of rats
given boric acid (H&E, x40). Liver damage was minimal in group
III. (Figures 5A and B).

used measurements are serum AST, ALT, and LDH values
[36]. When we looked at these values in our study we saw
that the values of the group 1 were low while the IR group
and BA group were high. When the IR group and the BA
group were compared there was no statistically significant
difference.
Cholestasis occurs in many situations in the clinic.
The most common causes are gallstones and benign and
malignant tumors. We followed the rats for 1 week after
ligation of the common bile duct to induce experimental
obstructive jaundice. In the case of cholestasis serum
bilirubin levels and ALP levels are the most investigated
parameters. When the groups were compared, total and
direct bilirubin levels and ALP were lower in the control
group while it was higher in the IR group and BA+IR group.
There was no statistically significant difference between the
IR and the BA+IR groups. The therapeutic effect of BA in
the early period did not reflected to associated laboratory
values for ALT/AST and bilirubin/ALP levels and as a
result there is not a statistically significant difference was
found between IR and IR-BA groups.
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SCUBE-1 is a new biomarker. Lindemann et al. found
the SCUBE-1 cDNA fragment restricted in the 22q13
chromosome in the endothelium and showed a fibrin-rich
region within the organized thrombus in platelets [37].
SCUBE-1 is stored in platelet α-granules and replaced
by platelet stimulation and activation at the cell surface.
Platelet SCUBE-1 exposed to the surface mediates
agglutination under thrombotic conditions. Studies have
reported in the literature that plasma SCUBE-1 values
started to increase in 6 h after platelet activation and
can be measured in plasma for an average of 3–4 days.
There are studies showing that SCUBE-1 levels increase
in pulmonary thromboembolism [38]. SCUBE-1 levels
have been shown to increase in experimental ischemic
stroke [39,40]. Another study showed that SCUBE-1 levels
started to increase within 2 h in acute mesenteric ischemia
[41]. One study reported that the SCUBE-1 level increased
in hemodialysis patients with no ischemic symptoms
and they attributed this to platelet dysfunction due to
hemodialysis [42]. In a study evaluating patients with
gastric cancer high SCUBE-1 values were found and it was
suggested that this may be associated with thrombosis due
to malignancy [43].
In our study, while SCUBE-1 levels were low in the
IR group it was significantly higher in the IR and BA+IR
group. This difference was not statistically significant in the
BA+IR group although it was lower in the IR group. With
these results, it is thought that SCUBE-1 can be used as a
biomarker in liver IR injury. Further studies are needed on
this subject. When we look at the total antioxidant capacity
we see that the group given BA was significantly higher
than the group 1 and IR groups. When we look at the total
oxidant capacity we see that the 3 groups are significantly
different from each other while the control group has the
lowest oxidant capacity while the IR group has the highest
oxidant capacity. BA group was statistically significantly
lower than IR group. With these data we can say that BA
increases antioxidant capacity and decreases oxidative
stress.
Although many mechanisms play a role in the
pathophysiology of IR injury the most important ones
are the increase of FOR and the increase of intracellular
calcium. While the increase in intracellular calcium
increases FOR levels, intracellular calcium increases further
with the disruption of the cell membrane structure. FOR
causes lipid peroxidation in the cell and organ membranes
[44]. It has been shown that boric acid reduces the levels
of malondialdehyde (MDA) which is a lipid peroxidation
product in aluminum-induced hepatotoxicity [45]. It has
been shown that the levels of superoxide dismutase (SOD)
enzyme which is an antioxidant in hepatotoxicity induced
by carbon tetrachloride increase with BA [27].

As a result of the activation of macrophages with
reperfusion, pro-inflammatory cytokine release increases
in the environment. In the studies of Başbuğ et al.
proinflammatory cytokines IL-6 and TNF-α were found to
be higher in the hepatic IR group but decreased in the BA
group [46].
Malondialdehyde (MDA) levels increased and
antioxidant reduced glutathione (GSH). superoxide
dismutase (SOD), and catalase (CAT) levels were found
to be decreased in the gentamicin-induced oxidative stress
experiment model in rats; in the group given BA it was
shown that MDA levels decreased. GSH, SOD, and CAT
levels increased [47]. In the ovarian IR experimental
model, the administration of 2-aminoethoxydiphenyl
borate (2-APB) showed that the TAS level was higher
and the TOS level was lower than the IR group [48]. In
a study conducted. It was shown that BA increased GSH.
SOD and CAT levels in formaldehyde-induced oxidative
stress, decreased the level of MDA, and decreased the
proinflammatory level of TNF-α [49]. In the experimental
necrotizing enterocolitis model it has been shown that
BA increases antioxidant mechanisms and decreases proinflammatory IL-6 and TN-α [50].
2-aminoethoxydiphenylborate (2-ABP) one of the
boron compounds is used in calcium channel stabilization.
Increase in intracellular and mitochondrial calcium forms
the basis of IR injury. In the literature, studies showing
that IR damage can be reduced by inhibiting intracellular
and microcrystalline calcium increase with 2-ABP in the
hepatic IR model [51,52]. A limitation of our study is that
although studies in large sample size and large animal
models are needed to evaluate the effectiveness for the
clinical application
In conclusion, to the best of our knowledge this is the
first experimental study in literature to have examined the
effect of BA on experimental IR injury of the cholestatic liver.
Liver tissue samples were examined histopathologically
and BA was seen to significantly reduce inflammation
and fibrosis. Again when TAS/TOS levels were examined
it was seen that BA increased the antioxidant capacity
and decreased the oxidant capacity. Thus the results of
the study demonstrated the hepatoprotective effect of
intraperitoneal BA administration before IR injury of
the cholestatic liver. Nevertheless, further experimental
and clinical studies are needed to better understand the
protective role and mechanism of BA.
Acknowledgement/Disclaimers/Conflict of interest
Funding
This research was funded by a grant from Antalya Training
and Research Hospital.
Conflict of interest
The authors declare that they have no conflict of interest.

2723

GÜLER et al. / Turk J Med Sci
References
1.

Lu TF, Yang TH, Zhong CP, Shen C, Lin WW et al. Dual effect
of hepatic macrophages on liver ischemia and reperfusion
injury during liver transplantation. Immune Network 2018; 18
(3): e24. doi: 10.4110/in.2018.18.e24

14.

Colak S, Geyikoglu F, Keles ON, Türkez H, Topal A et al. The
neuroprotective role of boric acid on aluminum chlorideinduced neurotoxicity. Toxicology and Industrial Health 2011;
27 (8): 700-710. doi: 10.1177/0748233710395349

2.

Nastos C, Kalimeris K, Papoutsidakis N, Tasoulis MK, Lykoudis
PM et al. Global consequences of liver ischemia/reperfusion
injury. Oxidative Medicine and Cellular Longevity 2014. doi:
10.1155/2014/90696

15.

Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin
binding and its potential as a marker for myocardial ischemia-a
preliminary report. The Journal of Emergency Medicine 2000;
19 (4): 311-315. doi: 10.1016/s0736-4679(00)00255-9

3.

Aragno M, Cutrin JC, Mastrocola R, Perrelli MG, Restivo F et
al. Oxidative stress and kidney dysfunction due to ischemia/
reperfusion in rat: attenuation by dehydroepiandrosterone.
Kidney International 2003; 64 (3): 836-843. doi: 10.1046/j.15231755.2003.00152.x

16.

Erel O. A new automated colorimetric method for measuring
total oxidant status. Clinical Biochemistry 2005; 38 (12): 11031111. doi: 10.1016/j.clinbiochem.2005.08.008

17.

Erel O. A novel automated direct measurement method for
total antioxidant capacity using a new generation, more stable
ABTS radical cation. Clinical Biochemistry 2004; 37 (4): 277285. doi: 10.1016/j.clinbiochem.2003.11.015

18.

Harma M, Harma M, Erel O. Increased oxidative stress in
patients with hydatidiform mole. Swiss Medical Weekly 2003;
133 (41-42): 563-566.

19.

Onder A, Kapan M, Gümüş M, Yüksel H, Böyük A et al. The
protective effects of curcumin on intestine and remote organs
against mesenteric ischemia/reperfusion injury. Turkish
Journal of Gastroenterology 2012; 23 (2): 141-147. doi:
10.4318/tjg.2012.0446

20.

Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to
ischemia/reperfusion injury in rat liver in vivo. FASEB Journal
1990; 4 (15): 3355-3359.

Tapuria N, Junnarkar S, Abu-Amara M, Fuller B, Seifalian AM
et al. Modulation of microcirculatory changes in the late phase
of hepatic ischaemia-reperfusion injury by remote ischaemic
preconditioning. HPB (Oxford) 2012; 14 (2): 87-97. doi:
10.1111/j.1477-2574.2011.00407.x

21.

Datta G, Fuller BJ, Davidson BR. Molecular mechanisms of
liver ischemia reperfusion injury: insights from transgenic
knockout models. World Journal of Gastroenterology 2013; 19
(11): 1683-1698. doi: 10.3748/wjg.v19.i11.1683

Çakır T, Aslaner A, Tekeli SÖ, Güneş K, Kinaci E et al. Grape
seed protects cholestatic rats liver from ischemia/reperfusion
injury. Acta Cirúrgica Brasileira 2016; 31 (3): 183-189. doi:
10.1590/S0102-865020160030000006

22.

Hunter, C. Boron. In Encyclopedia of Dietary Supplements.
Edited by B.M. Coates PM, Cragg GM, Levine M, Moss J and
White JD. Marcel Dekker, New York; 2005. pp. 55-65.

Khaliq H, Juming Z, Ke-Mei P. The physiological role of boron
on health. Biological Trace Element Research 2018; 186 (1): 3151. doi: 10.1007/s12011-018-1284-3

23.

Kar F, Hacioglu C, Senturk H, Donmez DB, Kanbak G. The role
of oxidative stress, renal inflammation, and apoptosis in post
ischemic reperfusion injury of kidney tissue: the protective
effect of dose-dependent boric acid administration. Biological
Trace Element Research 2020; 195 (1): 150-158. doi: 10.1007/
s12011-019-01824-1

24.

Hunt CD. The biochemical effects of physiologic amounts
of dietary boron in animal nutrition models. Environmental
Health Perspectives 1994; 102 (Suppl 7): 35-43. doi: 10.1289/
ehp.94102s735

25.

Nielsen FH. Nutritional requirements for boron, silicon,
vanadium, nickel, and arsenic: current knowledge and
speculation. FASEB Journal 1991; 5 (12): 2661-2667.

26.

Ozek NS, Yardimci BK, Yildirim S. Hepatoprotective role of
boric acid supplementation on liver injury induced by renal
ischemia-reperfusion. International Symposium on Affective
Science and Engineering 2018, 2018, 26.

4.

5.

6.

7.

8.

9.

Jaeschke H, Woolbright BL. Current strategies to minimize
hepatic ischemia-reperfusion injury by targeting reactive
oxygen species. Transplant Reviews (Orlando) 2012; 26 (2):
103-114. doi: 10.1016/j.trre.2011.10.006
Kloek JJ, Marsman HA, Van Vliet AK, Gouma DJ, Van Gulik
TM. Biliary drainage attenuates postischemic reperfusion
injury in the cholestatic rat liver. Surgery 2008; 144 (1): 22-31.
doi: 10.1016/j.surg.2008.03.030
Yoshidome H, Miyazaki M, Shimizu H, Ito H, Nakagawa K et
al. Obstructive jaundice impairs hepatic sinusoidal endothelial
cell function and renders liver susceptible to hepatic ischemia/
reperfusion. Journal of Hepatology 2000; 33 (1): 59-67. doi:
10.1016/s0168-8278(00)80160-9

10.

Nielsen FH. Is boron nutritionally relevant? Nutrition Reviews
2008; 66 (4): 183-191. doi: 10.1111/j.1753-4887.2008.00023.x

11.

Ince S, Kucukkurt I, Cigerci IH, Fatih Fidan A, Eryavuz A.
The effects of dietary boric acid and borax supplementation on
lipid peroxidation, antioxidant activity, and DNA damage in
rats. Journal of Trace Elements in Medicine and Biology 2010;
24 (3): 161-164. doi: 10.1016/j.jtemb.2010.01.003

12.

13.

Turkez H, Geyikoglu F, Tatar A, Keles MS, Kaplan I. The effects
of some boron compounds against heavy metal toxicity in
human blood. Experimental and Toxicologic Pathology 2012;
64 (1-2): 93-101. doi: 10.1016/j.etp.2010.06.011
Türkez H, Geyikoğlu F, Tatar A, Keleş S, Ozkan A. Effects
of some boron compounds on peripheral human blood.
Zeitschrift fur Naturforschung. C, Journal of Biosciences 2007;
62 (11-12): 889-896. doi: 10.1515/znc-2007-11-1218

2724

GÜLER et al. / Turk J Med Sci
27.

Ince S, Keles H, Erdogan M, Hazman O, Kucukkurt I. Protective
effect of boric acid against carbon tetrachloride-induced
hepatotoxicity in mice. Drug and Chemical Toxicology 2012;
35 (3): 285-292. doi: 10.3109/01480545.2011.607825

28.

Hazman Ö, Bozkurt MF, Fidan AF, Uysal FE, Çelik S. The effect
of boric acid and borax on oxidative stress, inflammation, ER
stress and apoptosis in cisplatin toxication and nephrotoxicity
developing as a result of toxication. Inflammation 2018; 41 (3):
1032-1048. doi: 10.1007/s10753-018-0756-0

29.

Sogut I, Oglakci A, Kartkaya K, Ol KK, Sogut MS et al. Effect
of boric acid on oxidative stress in rats with fetal alcohol
syndrome. Experimental and Therapeutic Medicine 2015; 9
(3): 1023-1027. doi: 10.3892/etm.2014.2164

30.

Yin M, Liu X, Chen X, Li C, Qin W et al. Ischemia-modified
albumin is a predictor of short-term mortality in patients
with severe sepsis. Journal of Critical Care 2017; 37: 7-12. doi:
10.1016/j.jcrc.2016.08.005

39.

Dai DF, Thajeb P, Tu CF, Chiang FT, Chen CH et al. Plasma
concentration of SCUBE1, a novel platelet protein, is elevated
in patients with acute coronary syndrome and ischemic stroke.
Journals of the American College of Cardiology 2008; 51 (22):
2173-2180. doi: 10.1016/j.jacc.2008.01.060

40.

Turkmen S, Eryigit U, Karaca Y, Mentese A, Sumer UA
et al. Diagnostic value of plasma signal peptide-Cub-Egf
domain-containing protein-1 (SCUBE-1) in an experimental
model of acute ischemic stroke. The American Journal of
Emergency Medicine 2015; 33 (2): 262-265. doi: 10.1016/j.
ajem.2014.11.051

41.

Turkmen S, Mentese S, Mentese A, Sumer AU, Saglam K et
al. The value of signal peptide-CUB-EGF domain-containing
protein 1 and oxidative stress parameters in the diagnosis of
acute mesenteric ischemia. Academic Emergency Medicine
2013; 20 (3): 257-264. doi: 10.1111/acem.12096

42.

Ulusoy S, Ozkan G, Menteşe A, Yavuz A, Karahan SC et
al. Signal peptide-CUB-EGF domain-containing protein 1
(SCUBE1) level in hemodialysis patients and parameters
affecting that level. Clinical Biochemistry 2012; 45 (16-17):
1444-1449. doi: 10.1016/j.clinbiochem.2012.07.103

31.

Gaze DC. Ischemia modified albumin: a novel biomarker
for the detection of cardiac ischemia. Drug Metabolism
and Pharmacokinetics 2009; 24 (4): 333-341. doi: 10.2133/
dmpk.24.333

43.

32.

Sbarouni E, Georgiadou P, Voudris V. Ischemia modified
albumin changes - review and clinical implications. Clinical
Chemistry and Laboratory Medicine 2011; 49 (2): 177-184.
doi: 10.1515/CCLM.2011.037

Mentese A, Fidan E, Sumer AU, Karahan SC, Sonmez M et
al. Is SCUBE 1 a new biomarker for gastric cancer? Cancer
Biomarkers 2012; 11 (5): 191-195. doi: 10.3233/CBM-201200285

44.

Kumar PA, Subramanian K. The role of ischemia modified
albumin as a biomarker in patients with chronic liver disease.
Journal of Clinical and Diagnostic Research 2016; 10 (3): 9-12.
doi: 10.7860/JCDR/2016/17168.7399

Jaeschke H. Molecular mechanisms of hepatic ischemiareperfusion injury and preconditioning. The American Journal
of Physiology-Gastrointestinal and Liver Physiology 2003; 284
(1): G15-26. doi: 10.1152/ajpgi.00342.2002 PMID: 12488232.

45.

Cakir M, Karahan SC, Mentese A, Sag E, Cobanoglu U et al.
Ischemia-modified albumin levels in children with chronic
liver disease. Gut and Liver 2012; 6 (1): 92-97. doi: 10.5009/
gnl.2012.6.1.92

Türkez H, Geyikoğlu F, Çolak S. The protective effect of boric
acid on aluminum-induced hepatotoxicity and genotoxicity in
rats. Turkish Journal of Biology 2011; 35: 293-301 doi: 10.3906/
biy-0902-11

46.

Basbug M, Yildar RM, Yaman I, Ozkan OF, Aksit H et al.
Effects of boric acid in an experimental rat model of hepatic
ischemia-reperfusion injury. Acta Medica Mediterranea 2015;
31 (5): 1067-1073.

47.

Kucukkurt I, Arslan-Acaroz D, Demirel HH, Ince S, Yavuz
A. Potential protective effect of boron against gentamicininduced oxidative stress on rat tissues Kocatepe Veterinary
Journal 2017; 10 (3): 172-179.

48.

Taskin MI, Hismiogullari AA, Yay A, Adali E, Gungor AC
et al. Effect of 2-aminoethoxydiphenyl borate on ischemiareperfusion injury in a rat ovary model. European Journal of
Obstetrics & Gynecology and Reproductive Biology 2014; 178:
74-79. doi: 10.1016/j.ejogrb.2014.03.049

49.

Arslan-Acaroz D, Bayşu-Sozbilir N. Ameliorative effect of
boric acid against formaldehyde-induced oxidative stress in
A549 cell lines. Environmental Science and Pollution Research
2020; 27 (4): 4067-4074. doi: 10.1007/s11356-019-06986-y

50.

Yazıcı S, Akşit H, Korkut O, Sunay B, Çelik T. Effects of boric acid
and 2-aminoethoxydiphenyl borate on necrotizing enterocolitis.
Journal of Pediatric Gastroenterology and Nutrition 2014; 58
(1): 61-67. doi: 10.1097/MPG.0b013e3182a7e02b

33.

34.

35.

36.

37.

38.

Dundar ZD, Cander B, Gul M, Karabulut KU, Girisgin S.
Serum ischemia-modified albumin levels in an experimental
acute mesenteric ischemia model. Academic Emergency
Medicine 2010; 17 (11): 1233-1238. doi: 10.1111/j.15532712.2010.00916.x
Aslaner A, Çakır T, Çelik B, Doğan U, Akyüz C et al.
The protective effect of intraperitoneal medical ozone
preconditioning and treatment on hepatotoxicity induced
by methotrexate. International Journal of Clinical and
Experimental Medicine 2015; 8 (8): 13303-13309
Lindemann S, Gawaz M. SCUBE1--a new scoop in vascular
biology? Cardiovascular Research 2006; 71 (3): 414-415. doi:
10.1016/j.cardiores.2006.06.005
Dirican N, Duman A, Sağlam G, Arslan A, Ozturk O et al.
The diagnostic significance of signal peptide-complement
C1r/C1s, Uegf, and Bmp1-epidermal growth factor domaincontaining protein-1 levels in pulmonary embolism. Annals of
Thoracic Medicine 2016; 11 (4): 277-282. doi: 10.4103/18171737.191876

2725

GÜLER et al. / Turk J Med Sci
51.

Jiang N, Zhang ZM, Liu L, Zhang C, Zhang YL et al. Effects of
Ca2+ channel blockers on store-operated Ca2+ channel currents
of Kupffer cells after hepatic ischemia/reperfusion injury in
rats. World Journal Gastroenterology 2006; 12 (29): 4694-4698.
doi: 10.3748/wjg.v12.i29.4694

2726

52.

Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM et
al. 2-APB protects against liver ischemia-reperfusion injury by
reducing cellular and mitochondrial calcium uptake. American
Journal of Physiology-Gastrointestinal and Liver Physiology
2007; 293 (3): 623-630. doi: 10.1152/ajpgi.00521.2006

